364 related articles for article (PubMed ID: 28481870)
1. Thrombospondin-4 mediates TGF-β-induced angiogenesis.
Muppala S; Xiao R; Krukovets I; Verbovetsky D; Yendamuri R; Habib N; Raman P; Plow E; Stenina-Adognravi O
Oncogene; 2017 Sep; 36(36):5189-5198. PubMed ID: 28481870
[TBL] [Abstract][Full Text] [Related]
2. Autocrine thrombospondin partially mediates TGF-beta1- induced proliferation of vascular smooth muscle cells.
Sajid M; Lele M; Stouffer GA
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2159-65. PubMed ID: 11045949
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
4. Proangiogenic Properties of Thrombospondin-4.
Muppala S; Frolova E; Xiao R; Krukovets I; Yoon S; Hoppe G; Vasanji A; Plow E; Stenina-Adognravi O
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1975-86. PubMed ID: 26139464
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.
McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK
Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629
[TBL] [Abstract][Full Text] [Related]
6. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.
Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938
[TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Mauro M; Kim J; Costello C; Laurence J
Am J Hematol; 2001 Jan; 66(1):12-22. PubMed ID: 11426486
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice.
Hayashi H; Sakai K; Baba H; Sakai T
Hepatology; 2012 May; 55(5):1562-73. PubMed ID: 22105716
[TBL] [Abstract][Full Text] [Related]
11. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.
Pollman MJ; Naumovski L; Gibbons GH
Circulation; 1999 Apr; 99(15):2019-26. PubMed ID: 10209007
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
Grainger DJ; Frow EK
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
14. P2Y4/TSP-1/TGF-β1/pSmad2/3 pathway contributes to acute generalized seizures induced by kainic acid.
Zhang Y; Zhu W; Yu H; Yu J; Zhang M; Pan X; Gao X; Wang Q; Sun H
Brain Res Bull; 2019 Jul; 149():106-119. PubMed ID: 31005663
[TBL] [Abstract][Full Text] [Related]
15. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
16. Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF.
Horiguchi H; Jin L; Ruebel KH; Scheithauer BW; Lloyd RV
Endocrine; 2004 Jul; 24(2):141-6. PubMed ID: 15347840
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.
Taraboletti G; Benelli R; Borsotti P; Rusnati M; Presta M; Giavazzi R; Ruco L; Albini A
J Pathol; 1999 May; 188(1):76-81. PubMed ID: 10398144
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
Daniel C; Wagner A; Hohenstein B; Hugo C
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
[TBL] [Abstract][Full Text] [Related]
19. Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation.
Kellouche S; Mourah S; Bonnefoy A; Schoëvaert D; Podgorniak MP; Calvo F; Hoylaerts MF; Legrand C; Dosquet C
Exp Cell Res; 2007 Feb; 313(3):486-99. PubMed ID: 17126831
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins.
Bequet-Romero M; López-Ocejo O
Biochem Biophys Res Commun; 2000 Oct; 277(1):55-61. PubMed ID: 11027639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
